RT Journal Article
SR Electronic
T1 Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco <em>et al</em>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP annrheumdis-2020-218528
DO 10.1136/annrheumdis-2020-218528
A1 Asim Khan
A1 Alice Cole
A1 Naveen Bhadauria
A1 Munzir El-Hassan
A1 Daud Abdulla
A1 Thomas Axon
A1 Zozik Fattah
A1 Jessica J Manson
A1 Jeronimo Moreno-Cuesta
A1 Dev Mukerjee
YR 2020
UL http://ard.bmj.com/content/early/2020/08/28/annrheumdis-2020-218528.abstract
AB